It is being developed for the treatment of inflammatory and fibrotic conditions such as systemic sclerosis, dermatomyositis and cystic fibrosis.
This treatment is aimed at managing inflammatory and fibrotic disorders like systemic sclerosis, dermatomyositis, and cystic fibrosis.